BGM Group (BGM) vs Spruce Biosciences (SPRB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Spruce Biosciences (SPRB) has outperformed BGM Group (BGM) over the past year, losing 71.6% versus a loss of 96.6%. Over five years, BGM leads with a -98.3% price change compared with -99.8% for SPRB. BGM Group is the larger company by market cap ($133.0 million vs $130.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGM | SPRB |
|---|---|---|
| Share price | $9.96 | $45.54 |
| Market cap | $133.01M | $130.88M |
| 1-day change | +6.07% | +2.57% |
| YTD return | -91.00% | -47.72% |
| 1-year return | -96.64% | -71.55% |
| 5-year return | -98.32% | -99.82% |
| Forward P/E | — | 9.15 |
| EPS (TTM) | $-4.80 | $-39.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $303.00 | $199.20 |
| 52-week low | $6.45 | $40.33 |
| Distance from 52-week high | -96.71% | -77.14% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +224.99% |
| Average volume | 6.09K | 77.75K |
| Shares outstanding | 12.69M | 2.87M |
| Employees | — | 22 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SPRB has outperformed BGM by 25.1 percentage points over the past year.
About BGM Group
BGM stock →BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments.
Health Care · Biotechnology: Pharmaceutical Preparations
About Spruce Biosciences
SPRB stock →Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.
Health Care · Biotechnology: Pharmaceutical Preparations · 22 employees
BGM vs SPRB FAQ
Which is bigger, BGM Group or Spruce Biosciences?
BGM Group (BGM) is larger, with a market capitalization of $133.01M compared with $130.88M for Spruce Biosciences (SPRB).
Which stock has performed better over the past year, BGM or SPRB?
SPRB returned -71.55% over the past 12 months, compared with -96.64% for BGM (price return, excluding dividends). Past performance does not predict future results.
Are BGM Group and Spruce Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.